Bayer Cropscience profit and loss

·ChemicalsChart ›
Latest FY26
Revenue
₹5,675cr+3.7% on FY25
EBITDA
₹874cr+26.7% on FY25
₹ crore except per share
Tap a line for its trendFY26Mar 2026FY25Mar 2025FY24Mar 2024FY22 and earlierAlpha Plus
5,6755,4735,103
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
95.012081.0
5,7705,5935,184
Expenses
3,1533,5862,718
220153139
−341−34153.9
438450435
19.817.019.6
94.084.974.0
986935787
4,9154,8864,243
874690954
780605880
Profit
——941
855707941
164151198
1.4−12.02.5
166139201
689568741
——3.5
677563744
Derived — gross profit (revenue − materials − purchases − Δ inventories)
2,6432,0752,192
46.6%37.9%42.9%
Adjusted (ex-exceptional items) — derived
——941
——741
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

BAYERCROP₹3,289.80

Bayer Cropscience Ltd.

· Chemicals
AnnualQuarterly₹ CrorePeersUPLPIINDRALLISATULSHKANURASCAMLINFINECLEAN
View
In ₹ Crore except Per Share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Revenue from Operations—5,103.25,473.45,675.0
Other Income—81.0119.795.0
Total Income—5,184.25,593.15,770.0
Expenses
+ Cost of Materials Consumed—2,718.43,586.43,152.5
+ Purchases of Stock-in-Trade—139.3153.0220.0
+ Changes in Inventories—53.9-340.6-340.6
+ Employee Benefit Expense—435.4449.8438.1
+ Finance Costs—19.617.019.8
+ Depreciation & Amortisation—74.084.994.0
+ Other Expenses—786.7935.2985.7
Total Expenses—4,242.84,885.74,915.1
EBITDA—954.0689.6873.7
EBIT—880.0604.7779.7
Profit
PBT before Exceptional Items—941.4——
Pretax Income—941.4707.4854.9
+ Current Tax—198.4151.4164.3
+ Deferred Tax—2.5-12.01.4
Tax Expense—200.9139.4165.7
Net Income—740.5568.0689.2
+ Other Comprehensive Income—3.5——
Total Comprehensive Income—744.0562.8677.1
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit—2,191.62,074.62,643.1
Gross Margin %—42.9537.9046.57
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)—941.4——
Net Income Adj (tax-effected)—740.5——
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 85%.